BetterLife Pharma BETRF
OTC BETRF
$0.17 +0.02 (+10.39%)
As of: Oct 21, 2026 · 12:20 PM EDT

BetterLife Pharma (BETRF) Current Debt (2018 - 2026)

Updated

BetterLife Pharma's Current Debt came in at -$591,530 for FY2019 (year ended Jan 31, 2019).

Analysis

BetterLife Pharma (BETRF) Current Debt (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -5.75 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 64.00 Mn
10 BetterLife Pharma 26.26 Mn 25.52 Mn - 0.72
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 0.72
Apr 30, 2026 188,437.24
Oct 31, 2023 211,955.74
Jul 31, 2023 164,824.84
Apr 30, 2023 1.18 Mn
Apr 30, 2018 -588,839.00
API Access

BetterLife Pharma Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=BETRF&period=max&api_key=YOUR_API_KEY